论文 · 体外 / 类器官研究
感觉神经元内源性mRNA的CRISPR-Cas敲低系统比较
Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons
作者:Andrea Meulenberg, Macarena Pavez, Emma K Gowing, David Mayo-Muñoz, Nils Birkholz, Graceallah Suhono, Peter C Fineran, Robert D Fagerlund, Laura F Gumy
CRISPR J · 2026年9月23日 · Meulenberg 等 9 位作者
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要)…
已等待 0 秒大约需要 10–20 秒
可以先看别的,做好了会自动出现在这里。
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。
摘要Abstract
Ribonucleic acid (RNA)-targeting clustered regularly interspaced short palindromic repeats-CRISPR-associated (CRISPR-Cas) systems enable modulation of gene expression without permanent genome modification, making them useful for sensitive cell types such as neurons. While CRISPR-Cas technologies have been most extensively applied and validated in primary hippocampal and cortical neurons, their use in sensory neurons remains largely unexplored. Sensory neurons are an established cellular model for studying axon growth and regeneration, pain mechanisms, sensory transduction, and neuron-environment interactions. Here, we evaluated the performance of compact RNA-targeting CRISPR-Cas effectors Cas7-11S, hfCas13X, and hfCas13d in primary rat sensory neurons in culture. Using an endogenous mRNA as the target, we compared knockdown efficiency and assessed the effects of CRISPR-Cas expression on neuronal health. The systems showed distinct differences in performance, with Cas7-11S inducing toxicity, hfCas13X showing minimal knockdown, and hfCas13d providing robust gene silencing with minimal adverse effects on neuronal health. These findings identify hfCas13d as the most effective and well-tolerated RNA-targeting CRISPR-Cas tool for sensory neurons and provide important insight into its suitability for neuroscience research and potential therapeutic applications.
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究,以及之后引用它的研究,并说明每篇为什么相关。